H1N1 Update

WHO reports.

39620

167

. Biomedreports is running an article about the mutations seen in the H1N1 virus.
Related stocks mentioned include:
Antivirals:
GILD, GSK, BTAHY.PK, RHHBY.PK
NVAX HEB

Excerpts from the Biomed reports article are reproduced below: The new strain of influenza appears to have mutated to become more infectious for humans, the online edition of science magazine Nature reported, referencing research by a team including Professor Yoshihiro Kawaoka of Tokyo University's Institute of Medical Science.

The surface of influenza virus particles are covered with thorn-shaped proteins called hemagglutinin (HA), which allows the virus to stick to human cells. The surface of influenza virus particles are covered with thorn-shaped proteins called hemagglutinin (HA), which allows the virus to stick to human cells.

After analyzing multiple samples of the new flu virus, the team ascertained that in some cases the HA of the new H1N1 strain have mutated, allowing the strain to stick to human cells more easily. After analyzing multiple samples of the new flu virus, the team ascertained that in some cases the HA of the new H1N1 strain have mutated, allowing the strain to stick to human cells more easily.

There is no other big news to report today, so just read BBC instead.
The Swine Flu Survival Guide Click Here!